Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40].

Auvray, Marie; Auclin, Edouard; Barthelemy, Philippe; Bono, Petri; Kellokumpu-Lehtinen, Pirkko; Gross-Goupil, Marine; De Velasco, Guillermo; Powles, Thomas; Mouillet, Guillaume; Vano, Yann-Alexandre; Gravis, Gwenaëlle; Mourey, Loïc; Priou, Franck; Rolland, Frédéric; Escudier, Bernard; Albiges, Laurence

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/72375

Title:	Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40].
Authors:	Auvray, Marie Auclin, Edouard Barthelemy, Philippe Bono, Petri Kellokumpu-Lehtinen, Pirkko Gross-Goupil, Marine De Velasco, Guillermo Powles, Thomas Mouillet, Guillaume Vano, Yann-Alexandre Gravis, Gwenaëlle Mourey, Loïc Priou, Franck Rolland, Frédéric Escudier, Bernard Albiges, Laurence View more
Issue Date:	11-Jul-2019
Citation:	Eur J Cancer.2019;(119):200-201
PMID:	31301937
URI:	https://hdl.handle.net/20.500.12530/72375
Appears in Collections:	Hospitales > H. U. 12 de Octubre > Artículos

Files in This Item:

The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.

Show full item record